PTC Therapeutics Announces Initiation of Phase 2/3 Clinical Trial in Australia to Evaluate PTC299 for the Treatment of COVID-19
- Written by PR Newswire Asia - News Pronto RSS
– Oral treatment with novel dual-mechanism of action has the potential to address the two critical elements of COVID-19: viral replication and uncontrolled inflammatory response –
– Randomized, double-blind, placebo-controlled, Phase 2/3 clinical study with two stages initiated at several sites in Australia –
– Also...